Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Faraday Future robotics unit forecasts USD 45.17 million 2027 revenue

Faraday Future robotics unit forecasts USD 45.17 million 2027 revenue

BitgetBitget2026/09/30 01:00
  • Faraday Future forecast 2026 “Four-Core Full-Stack AI” ecosystem revenue of about $7.1 million.
  • Projected 2027 ecosystem revenue of about $45.17 million; five-year cumulative revenue forecast of about $1.98 billion.
  • Targets positive quarterly operating cash flow in Q3 2028; aims for more than 130,000 cumulative EAI Device unit sales over five years.
  • Outlook follows 552 cumulative shipments by end-August; Q2 2026 unaudited average gross margin about 30.9% on robotics products.
  • Reported cumulative revenue of about $1.52 million; robotics business valuation referenced at about $200 million in proposed all-stock AIxC deal.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faraday Future Intelligent Electric Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609292100BIZWIRE_USPR_____20260929_BW114466) on September 30, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly

The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.

智通财经•2026/10/13 02:41

Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results

Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.

智通财经•2026/10/13 01:56